A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis
about
Pharmacological treatments for fatigue associated with palliative carePharmacological treatments for fatigue associated with palliative careThe cyclooxygenase-2 pathway via the PGE₂ EP2 receptor contributes to oligodendrocytes apoptosis in cuprizone-induced demyelinationThe Berlin Treatment Algorithm: recommendations for tailored innovative therapeutic strategies for multiple sclerosis-related fatigueMeta-analysis of three different types of fatigue management interventions for people with multiple sclerosis: exercise, education, and medicationBody temperature is elevated and linked to fatigue in relapsing-remitting multiple sclerosis, even without heat exposure.Protease-activated receptor-1 activation by granzyme B causes neurotoxicity that is augmented by interleukin-1βCyclooxygenase-2 expression in oligodendrocytes increases sensitivity to excitotoxic deathSymptomatic therapy in multiple sclerosis: a review for a multimodal approach in clinical practice.Aspirin and multiple sclerosisTreatment of symptoms in multiple sclerosis.Fatigue and fatigability in neurologic illnesses: proposal for a unified taxonomy.Origin of fatigue in multiple sclerosis: review of the literature.Treatment of fatigue in multiple sclerosis: a systematic review of the literature.The treatment of fatigue.Inflammation in Depression and the Potential for Anti-Inflammatory TreatmentTreatment of multiple sclerosis in children and adolescents.Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease.Multiple sclerosis-associated fatigue.Management options in multiple sclerosis-associated fatigue.Fatigue in healthy and diseased individuals.Managing Disability in Progressive Multiple Sclerosis.Inflammation and the Silent Sequelae of Stroke.A multicenter randomized controlled trial of two group education programs for fatigue in multiple sclerosis: Short- and medium-term benefits.HAGIL (Hamburg Vigil Study): a randomized placebo-controlled double-blind study with modafinil for treatment of fatigue in patients with multiple sclerosis.Fatigue as a symptom or comorbidity of neurological diseases.Aspirin is an effective pretreatment for exercise in multiple sclerosis: A double-blind randomized controlled pilot trial.[Therapy of fatigue in multiple sclerosis : A treatment algorithm].Elevated body temperature is linked to fatigue in an Italian sample of relapsing-remitting multiple sclerosis patients.Effect of a water extract of Curcuma longa on emotional states in healthy participants.
P2860
Q24187756-9F059A3B-2B3F-4FDF-84D8-4BE6B8584242Q24236457-84E24083-C885-4F88-B1FC-4E0071748E13Q24596035-D995AE49-1E46-4149-9CA2-6999997F8219Q28073849-A4057503-FBE9-4C12-8138-5D5A4EAAE6E9Q33735739-664E8968-8489-4BAD-8B43-972C0B016FF3Q33807332-FD2A43A6-D6E5-422A-8A01-101F59D2A131Q33846630-B09C50EC-AD5E-4B62-9E03-2C6191A26D91Q33863351-6C3227C9-67E1-4C2F-924A-B35530C02A59Q35018491-393700A4-7DC1-4D50-930D-F2F6D083AC58Q35678040-E9E0AAF5-B726-4952-8D9C-88BF5C266F7BQ36474348-3FB9CD2D-D245-40A2-80FE-889E5C10C65EQ36659579-BA922417-F45D-44EF-9767-66627ED5043FQ36780439-F0FD4C20-A7E9-4BA1-8CD8-DB4630ED3E8EQ37100322-1647CB71-B237-490E-8FE2-0B81898E540DQ37238934-A46C2A9F-4115-47D7-B6DC-7AAFA46786CAQ37310528-977829BA-DA04-4161-B95C-82E66BC50036Q37693918-C30D6713-59DC-4B53-9EB8-169198E863BCQ37749714-EEB4DA56-F3E2-4BAC-95C1-CAA96E4A28FAQ37785555-7FCE494E-0841-40B4-975B-70C00AF0FB99Q37973392-223E9274-695B-472E-9611-5B5807A83094Q38124676-C0556475-3889-4D63-916D-E397C9A067DDQ38811069-47B31907-9F58-49C7-B96C-CCD3AD4D0895Q38871034-5AF864E8-18EE-4266-B085-FF0EC0EF89C3Q47654976-56944E35-F859-40D2-954F-F39C135CD22CQ48303575-22C0FFBE-7DFA-4FE1-B03E-03AC9D509033Q50063088-AF585371-44F8-4210-95CC-FCAA1E708A6EQ50094817-5620732F-B000-44ED-B38F-08515FA12A68Q52849592-6BDA1753-D241-4F9B-B6F6-4A6CE87C82D0Q53402362-DCCB4342-68D0-49F8-A67C-2E6F889B1CE8Q55261860-6F592E19-5D4A-456D-820C-48689DD3DC94
P2860
A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis
@ast
A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis
@en
A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis
@nl
type
label
A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis
@ast
A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis
@en
A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis
@nl
prefLabel
A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis
@ast
A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis
@en
A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis
@nl
P2093
P1433
P1476
A randomized controlled crossover trial of aspirin for fatigue in multiple sclerosis
@en
P2093
B G Weinshenker
B M Keegan
C F Lucchinetti
D M Wingerchuk
E E Benarroch
J H Noseworthy
M Rodriguez
P C O'Brien
P304
P356
10.1212/01.WNL.0000156803.23698.9A
P407
P577
2005-04-12T00:00:00Z